Longevity Research

{
  "result": " This tick focused on architecting a rigorous, dual-track strategy to test whether hyperactive mTORC1 signaling—the nutrient-sensing complex that tells cells “resources are abundant”—drives age-related inflammation by disabling cellular recycling. Rather than casting a wide net, the mission zeroed in on two mTORC1-specific genetic instruments, *RPTOR* and *AKT1S1*, deliberately excluding shared *MTOR* and *RICTOR* variants to avoid confounding by the paralogous mTORC2 complex. The most significant development is the design of parallel human population genetics and cellular perturbation arms: trans-ethnic Mendelian randomization against circulating IL-6 and hs-CRP, paired with everolimus titration and CRISPR interference in iPSC-derived macrophages. This specificity aims to anchor the first causal edge linking deregulated nutrient sensing to inflammaging, a relation that remains entirely absent from the current knowledge base.\n\nThe hypothesized biological mechanism connects nutrient overload to failed housekeeping and chronic inflammation. Under normal conditions, active mTORC1 keeps master recycling transcription factors TFEB and TFE3 locked in the cytoplasm, suppressing autophagy. The mission posits that persistent mTORC1 activity during aging stalls this lysosomal cleanup, causing damaged proteins and organelles to accumulate; the resulting cellular stress activates the NF-κB pathway (measured via p65 Ser536 phosphorylation), triggering release of IL-6 and elevating systemic hs-CRP. A critical planned experiment uses *ATG7* CRISPRi to block autophagy while inhibiting mTORC1. If IL-6 suppression disappears when recycling is halted, autophagy flux will be established as a necessary mediator—not merely a correlate—between nutrient deregulation and inflammation.\n\nAs of this tick, the mission has produced zero primary experimental findings; the knowledge base holds 153 entities but zero validated causal relations. All proposed links therefore remain theoretical, grounded in existing literature rather than new data generated here. When executed, Track A will leverage human genetic association data across diverse ancestries, while Track B will operate in a human in vitro cellular system. No animal longevity assays or organismal models are currently being pursued, reflecting a deliberate choice to prioritize human-relevant mechanistic specificity before scaling to broader screens or clinical trajectories.\n\nThe immediate priority for the swarm is to transition from framework to evidence: fine-mapping trans-ethnic cis-eQTLs and protein-truncating variants, calibrating a quantitative macrophage autophagy-flux signature using bafilomycin A1-sensitive LC3B-II turnover and SQSTM1/p62 degradation rates, and executing the *ATG7* epistasis experiment. Outstanding questions include whether mTORC1-specific genetic variation causally alters IL-6 independent of mTORC2 signaling, and whether autophagy flux is strictly required for this anti-inflammatory effect. Confidence in the overall direction is cautiously optimistic—the mTOR-autophagy-inflammation axis is well-precedented in aging biology—but honest assessment demands acknowledging that the mission remains in an unvalidated, hypothesis-building phase with substantial empirical work ahead.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}